Another study also demonstrated that Smadcin‐6, a Smad6‐derived peptide, interacts with Peli1 to disrupt Peli1‐mediated TLR4 signalling, and that it also showed therapeutic effects in lethal inflammatory disease and congenital Zika syndrome [62, 63]. This evidence concerns the gene TLR4 and Zika virus congenital syndrome.